Stockscreener 앱 받기
1.44
4.35%
0.06
시간 외 거래:
1.46
0.02
+1.39%
전일 마감가:
$1.38
열려 있는:
$1.39
하루 거래량:
112.91K
Relative Volume:
0.26
시가총액:
$87.23M
수익:
-
순이익/손실:
$-64.86M
주가수익비율:
-1.2857
EPS:
-1.12
순현금흐름:
$-55.66M
1주 성능:
+5.88%
1개월 성능:
+5.88%
6개월 성능:
+17.07%
1년 성능:
-36.56%
1일 변동 폭
$1.38
$1.46
1주일 범위
$1.335
$1.46
52주 변동 폭
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
명칭
Acumen Pharmaceuticals Inc
전화
617-344-4190
주소
1210-1220 WASHINGTON STREET, NEWTON
ABOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
1.44 | 83.59M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-07-26 | 개시 | Citigroup | Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-07-20 | 재개 | BofA Securities | Buy |
| 2023-05-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-15 | 개시 | BTIG Research | Buy |
| 2022-06-30 | 개시 | H.C. Wainwright | Buy |
| 2022-01-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-07-26 | 개시 | BofA Securities | Neutral |
| 2021-07-26 | 개시 | Credit Suisse | Outperform |
| 2021-07-26 | 개시 | Stifel | Buy |
| 2021-07-26 | 개시 | UBS | Buy |
모두보기
Acumen Pharmaceuticals Inc 주식(ABOS)의 최신 뉴스
Applying Wyckoff theory to Acumen Pharmaceuticals Inc. stock2025 Market Overview & Weekly High Return Opportunities - Newser
Can Acumen Pharmaceuticals Inc. sustain earnings growthWeekly Stock Report & Risk Adjusted Buy/Sell Alerts - خودرو بانک
How do insiders feel about Acumen Pharmaceuticals Inc.Quarterly Trade Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Does Acumen Pharmaceuticals Inc. stock have upside surprise potentialWeekly Profit Recap & Free Technical Pattern Based Buy Signals - خودرو بانک
Should I add Acumen Pharmaceuticals Inc. stock to my portfolioMarket Volume Summary & Low Risk Growth Stock Ideas - خودرو بانک
Is Acumen Pharmaceuticals Inc. stock heavily shorted2025 Short Interest & Stepwise Entry and Exit Trade Signals - خودرو بانک
Does Acumen Pharmaceuticals Inc. have declining or rising EPSWatch List & Stepwise Swing Trade Plans - خودرو بانک
Is Acumen Pharmaceuticals Inc. stock a good pick for beginnersWeekly Trade Report & Technical Entry and Exit Tips - خودرو بانک
is acumen pharmaceuticals inc. building a consolidation baseWeekly Investment Recap & Weekly High Conviction Ideas - Newser
What dividend growth rate does Acumen Pharmaceuticals Inc. offerJuly 2025 Short Interest & High Return Trade Guides - خودرو بانک
Short interest data insights for Acumen Pharmaceuticals Inc.Trade Risk Assessment & Weekly High Conviction Ideas - Newser
Is Acumen Pharmaceuticals Inc. stock entering bullish territory2025 Short Interest & Long-Term Safe Investment Plans - Newser
Technical analysis overview for Acumen Pharmaceuticals Inc. stockTrade Performance Summary & Risk Controlled Swing Alerts - Newser
What’s the RSI of Acumen Pharmaceuticals Inc. stockPortfolio Growth Summary & Weekly Watchlist of Top Performers - خودرو بانک
Acumen Pharmaceuticals (NASDAQ:ABOS) vs. WAVE Life Sciences (NASDAQ:WVE) Head-To-Head Contrast - Defense World
Published on: 2025-09-05 00:26:02 - Newser
What hedge funds are buying Acumen Pharmaceuticals Inc.2025 Retail Activity & Low Drawdown Trading Strategies - 더경남뉴스
Using data tools to time your Acumen Pharmaceuticals Inc. exit2025 Major Catalysts & Reliable Entry Point Trade Alerts - Newser
What institutional flow reveals about Acumen Pharmaceuticals Inc.July 2025 Market Mood & Accurate Intraday Trade Tips - Newser
Tick level data insight on Acumen Pharmaceuticals Inc. volatility2025 Market Outlook & Growth Focused Investment Plans - Newser
Should you wait for a breakout in Acumen Pharmaceuticals Inc.Quarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - Newser
Leading vs lagging indicators on Acumen Pharmaceuticals Inc. performance2025 Investor Takeaways & Expert Approved Trade Ideas - Newser
Can Acumen Pharmaceuticals Inc. sustain its profitability2025 Fundamental Recap & Reliable Breakout Forecasts - خودرو بانک
Multi factor analysis applied to Acumen Pharmaceuticals Inc.2025 Bull vs Bear & Verified Entry Point Detection - Newser
Can you recover from losses in Acumen Pharmaceuticals Inc.Quarterly Trade Report & High Win Rate Trade Tips - Newser
Is Acumen Pharmaceuticals Inc. stock technically oversoldWeekly Stock Recap & AI Powered Market Trend Analysis - خودرو بانک
Can Acumen Pharmaceuticals Inc. recover in the next quarterInflation Watch & Real-Time Buy Signal Alerts - Newser
Volume spikes in Acumen Pharmaceuticals Inc. stock – what they mean2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
News impact scoring models applied to Acumen Pharmaceuticals Inc.July 2025 PostEarnings & Weekly Hot Stock Watchlists - Newser
Can Acumen Pharmaceuticals Inc. ride the EV waveMarket Activity Report & Expert Verified Movement Alerts - خودرو بانک
Will earnings trigger a reversal in Acumen Pharmaceuticals Inc.July 2025 Update & Accurate Intraday Trading Signals - Newser
Is Acumen Pharmaceuticals Inc. building a consolidation baseAnalyst Upgrade & Short-Term High Return Strategies - Newser
Is Acumen Pharmaceuticals Inc. a play on infrastructure spendingJuly 2025 Volume & Weekly High Momentum Picks - خودرو بانک
What to expect from Acumen Pharmaceuticals Inc. in the next 30 daysIndex Update & AI Driven Price Forecasts - Newser
Will Acumen Pharmaceuticals Inc. rebound enough to break evenWeekly Market Report & Comprehensive Market Scan Reports - Newser
Can Acumen Pharmaceuticals Inc. expand into new marketsGap Up & Low Risk Investment Opportunities - خودرو بانک
Is Acumen Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Institutional & Accurate Technical Buy Alerts - Newser
Acumen Pharmaceuticals at Citi’s Biopharma: Strategic Insights on Alzheimer’s - Investing.com
What MACD signals say about Acumen Pharmaceuticals Inc.2025 Sector Review & Technical Analysis for Trade Confirmation - Newser
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth - MSN
What’s next for Acumen Pharmaceuticals Inc. stockCEO Change & Fast Exit Strategy with Risk Control - خودرو بانک
Is Acumen Pharmaceuticals Inc. stock good for income investorsJuly 2025 Review & Low Risk Entry Point Tips - خودرو بانک
Acumen Pharmaceuticals' Q2 Earnings Call Highlights Strategic Growth and Alzheimer's Therapy Advancements - AInvest
Market reaction to Acumen Pharmaceuticals Inc.’s recent newsQuarterly Profit Summary & Reliable Trade Execution Plans - Newser
Acumen Pharmaceuticals Inc (ABOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acumen Pharmaceuticals Inc 주식 (ABOS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zuga Matt | CFO & Chief Business Officer |
Jan 21 '25 |
Sale |
1.60 |
4,364 |
6,986 |
260,646 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '25 |
Sale |
1.59 |
12,619 |
20,102 |
667,488 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '25 |
Sale |
1.59 |
3,418 |
5,435 |
161,127 |
| Barton Russell | Chief Operating Officer |
Jan 21 '25 |
Sale |
1.61 |
2,914 |
4,692 |
136,117 |
| Siemers Eric | Chief Medical Officer |
Jan 21 '25 |
Sale |
1.59 |
3,219 |
5,118 |
170,298 |
1.40%
자본화:
|
볼륨(24시간):